メニュー
Request a Quote
お問い合わせ
JP
Best practices to measure cytokines in whole blood with AlphaLISA
Application Note

Best practices to measure cytokines in whole blood with AlphaLISA

Unlock the potential of whole blood analysis for a more accurate and physiologically relevant assessment of biomarkers. Whole blood encompasses all the natural components of blood, offering an environment that enhances cell viability and simplifies the analytical process by reducing the need for extensive sample preparation. This comprehensive matrix allows for a better understanding of cytokine profiles and other critical biomarkers directly in their native state.

For researchers utilizing whole blood samples or seeking to integrate this method into their work, Revvity's AlphaLISA™ technology offers a highly sensitive, homogeneous assay for efficient and precise biomarker detection in whole blood. Download this application note to explore how AlphaLISA can streamline your biomarker analysis, delivering reliable results while overcoming the typical challenges associated with whole blood samples.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Best practices to measure cytokines in whole blood with AlphaLISA

Download Application Note